Published through 2026-11-02 17:05 UTC · Automated cloud publishing.
2026 Eyewear Sector Investment Report: Ollin Biosciences, Science Corporation and Even Realities Lead Funding Rounds
Understand the event
Optik (Sweden) has released a summary of the largest eyewear-related startup investments for 2026. The report highlights three key companies leading funding rounds: Ollin Biosciences, Science Corporation, and Even Realities. According to the reporting, San Diego-based Ollin Biosciences secured the year's most significant single investment round, raising $330 million in June. This substantial capital injection is designated for Phase 3 clinical studies focused on diabetic macular edema, indicating a strong intersection between advanced biotechnology and the broader eyewear sector. While the headline identifies Science Corporation and Even Realities as other leaders in this funding landscape, the provided excerpt details only the specific financial achievement of Ollin Biosciences. The report underscores the scale of venture capital flowing into innovative eye health and wearable technology solutions during 2026. No conflicting data or alternative figures are presented in this latest update regarding the total amounts raised by the other mentioned entities, leaving their specific contributions undefined within this text fragment.
AI-generated from reporting · updated 18 days ago
Reporting timeline
Follow the reporting for different perspectives.
- Optik (Sweden)2026 Eyewear Sector Investment Report: Ollin Biosciences, Science Corporation and Even Realities Lead Funding Rounds
Optik (Sweden) summarized the largest eyewear-related startup investments of 2026. San Diego-based Ollin Biosciences secured the year's biggest single round with $330 million in June for Phase 3 studies on diabetic macular edema treatments. Science Corporation, led by Max Hodak, raised $230 million in March to commercialize its PRIMA retinal implant, which uses special glasses to restore vision for geographic atrophy patients; the company plans a near-term European launch. Shenzhen-based Even Realities raised $150 million in July, reaching a $1 billion valuation for its camera-free smart glasses with built-in displays. Chinese competitors RayNeo and Xreal also raised over $100 million each. The analysis notes that funding concentrated on pharmaceuticals, implants, and consumer electronics, while traditional optical services attracted less investment.